Organogenesis Holdings (ORGO) Gains from Investment Securities (2018 - 2021)
Organogenesis Holdings (ORGO) posted quarterly Gains from Investment Securities of -$927000.0 for Q3 2021, up 66.44% quarter-over-quarter from -$2.8 million in Q2 2021.
Organogenesis Holdings (ORGO) Gains from Investment Securities (2018 - 2021) Analysis & Trends
Organogenesis Holdings' Gains from Investment Securities history runs 2 years deep, the most recent figure standing at -$927000.0 for Q3 2021.
- In Q3 2021, Gains from Investment Securities changed N/A year-over-year to -$927000.0; the TTM figure through Jun 2022 stood at -$927000.0 (up 67.34% YoY), while the FY2021 annual figure was -$4.0 million, down 2063.05% from the prior year.
- Gains from Investment Securities for Q3 2021 stood at -$927000.0, up from -$2.8 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $176000.0 in Q2 2018, with the low at -$2.8 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Organogenesis Holdings | 229.04 Mn | 182.20 Mn | 20.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -927,000.00 |
| Sep 30, 2021 | -927,000.00 |
| Jun 30, 2021 | -2.76 Mn |
| Jun 30, 2021 | -2.76 Mn |
| Mar 31, 2021 | -296,000.00 |
| Mar 31, 2021 | -296,000.00 |
| Dec 31, 2018 | 170,000.00 |
| Dec 31, 2018 | 170,000.00 |
| Sep 30, 2018 | 50,000.00 |
| Sep 30, 2018 | 50,000.00 |
| Jun 30, 2018 | 176,000.00 |
| Jun 30, 2018 | 176,000.00 |
| Mar 31, 2018 | 73,000.00 |
| Mar 31, 2018 | 73,000.00 |